Hikma Pharmaceuticals Plc Holding(s) in Company (6781C)
October 19 2015 - 6:11AM
UK Regulatory
TIDMHIK
RNS Number : 6781C
Hikma Pharmaceuticals Plc
19 October 2015
Notification of major interests in shares
LONDON, 19 October 2015 - Hikma Pharmaceuticals PLC ("Hikma")
(LSE: HIK) (DIFX: HIK), the fast growing multinational
pharmaceuticals group, announces as follows:
1 Identity of the issuer or the underlying Hikma Pharmaceuticals PLC
issuer of existing shares to which the
voting rights are attached
2 Reason for the notification
An acquisition or disposal of voting rights Yes
--------------------------------------------------------- ----
An acquisition or disposal of financial instruments No
which may result in the acquisition of shares already
issues to which voting rights are attached
--------------------------------------------------------- ----
An event changing the breakdown of voting rights No
--------------------------------------------------------- ----
Other (please specify): Compliance with the Transparency No
Directive
--------------------------------------------------------- ----
3 Full name of the person subject to the FMR LLC
notification obligation
4 Full name of shareholders See Section 9
--------------------------------------------------------------- -------------------------------------
5 Date of the Transaction (and date on 15(th) October 2015
which the threshold crossed is reached
differently)
--------------------------------------------------------------- -------------------------------------
6 Date on which the issuer notified 16(th) October 2015
--------------------------------------------------------------- -------------------------------------
7 Threshold that is crossed 5%
--------------------------------------------------------------- -------------------------------------
8 Notified details See A, B & C below
----- --------------------------------------------------------------- -------------------------------------
A. Voting rights attached to shares
Class type Situation previous Resulting situation after the triggering
of shares to the triggering transaction
(if possible transaction
using the
ISIN code)
------------------------ -----------------------------------------------------------------
Number Number Number of shares Number of voting % of voting
of shares of voting rights rights
rights
----------- ----------- ------------------- --------------------- ---------------------
Direct Indirect Direct Indirect Direct Indirect
----------- ----------- ------- ---------- --------- ---------- ------- ------------
Ordinary
Shares (0.10
GBP)
GB00B0LCW083 10,012,619 10,012,619 9,940,020 9,940,020 4.98%
----------- ----------- ------- ---------- --------- ---------- ------- ------------
B. Qualifying Financial instruments
Resulting situation after the triggering transaction
Type of financial Expiration Exercise/Conversion Number of voting % of voting rights
instrument Date Period/Date rights that may
be acquired if
the instrument
if exercised/converted
----------- -------------------- ------------------------ -------------------
- - - - -
----------- -------------------- ------------------------ -------------------
C: Financial Instruments with similar economic effect to Qualifying
Financial Instruments
Resulting situation after the triggering transaction
Type of Exercise Expiration Exercise/Conversion Number of voting % of voting rights
financial Price Date Period/Date rights instrument
instrument refers to
--------- ----------- -------------------- ------------------- ---------------------
Nominal Delta
--------- ----------- -------------------- ------------------- ----------- --------
- - - - - - -
--------- ----------- -------------------- ------------------- ----------- --------
Total A+B+C
Number of Voting rights % of voting rights
-------------------
9,940,020 4.98
-------------------
9 Chain of controlled undertakings through which the voting rights
and/or the financial instruments are effectively held, if applicable
Custodian Day to Day IM Total
BANK OF NEW YORK PGALLC-PYRAMIS GLOBAL ADVISORS,
BRUSSELS (C) LLC 8,485
BANK OF NEW YORK PGALLC-PYRAMIS GLOBAL ADVISORS,
MELLON LLC 126,481
BROWN BROTHERS HARRIMAN
AND CO FMRC-FMR CO., INC 62,684
FMRIMUK-FMR INVESTMENT MANAGEMENT
(UK) LIMITED 45,683
PGALLC-PYRAMIS GLOBAL ADVISORS,
LLC 65,599
PYRAMIS GLOBAL-PYRAMIS GLOBAL ADVISORS
TRUST COMPANY 701,393
CIBC MELLON TRUST PGALLC-PYRAMIS GLOBAL ADVISORS,
(C) LLC 13,333
CITIBANK NA, HONG PGALLC-PYRAMIS GLOBAL ADVISORS,
KONG BR (S) LLC 16,382
JP MORGAN, BOURNEMOUTH PGALLC-PYRAMIS GLOBAL ADVISORS,
(C) LLC 9,809
PYRAMIS GLOBAL-PYRAMIS GLOBAL ADVISORS
TRUST COMPANY 147,035
JPMORGAN CHASE BANK FMRC-FMR CO., INC 3,738,352
FMRIMUK-FMR INVESTMENT MANAGEMENT
(UK) LIMITED 151,087
PGALLC-PYRAMIS GLOBAL ADVISORS,
LLC 44,698
PYRAMIS GLOBAL-PYRAMIS GLOBAL ADVISORS
TRUST COMPANY 66,040
PGALLC-PYRAMIS GLOBAL ADVISORS,
MELLON BANK NA (C) LLC 318,448
NATIONAL ASTL BK PYRAMIS GLOBAL-PYRAMIS GLOBAL ADVISORS
MELBOURNE (S) TRUST COMPANY 57,922
NATIONAL BANK TRUST PYRAMIS GLOBAL-PYRAMIS GLOBAL ADVISORS
(C) TRUST COMPANY 14,829
NOMURA TRUST AND PGALLC-PYRAMIS GLOBAL ADVISORS,
BANKING (C) LLC 670
NORTHERN TRUST CO
(C) FMRC-FMR CO., INC 188,816
FMRIMUK-FMR INVESTMENT MANAGEMENT
(UK) LIMITED 2,598,333
PGALLC-PYRAMIS GLOBAL ADVISORS,
LLC 42,554
PYRAMIS GLOBAL-PYRAMIS GLOBAL ADVISORS
TRUST COMPANY 303,271
STATE STREET BANK
AND TR CO FMRC-FMR CO., INC 225,374
PGALLC-PYRAMIS GLOBAL ADVISORS,
LLC 554,286
PYRAMIS GLOBAL-PYRAMIS GLOBAL ADVISORS
TRUST COMPANY 438,456
Grand Total 9,940,020
---------------------------------------------------------------------------------
Proxy Voting
10 Name of the proxy holder FMR LLC
-------------------------------------- --------------------
Number of voting rights proxy holder
11 will cease to hold 72,599
-------------------------------------- --------------------
12 Date on which proxy holder will cease 15(th) October 2015
to hold voting rights
-------------------------------------- --------------------
13 Additional Information
14 Contact name: Peter Speirs, Company Secretary
-------------------------- --------------------------------
15 Contact telephone number: 020 7399 2772
-------------------------- --------------------------------
- ENDS -
About Hikma
(MORE TO FOLLOW) Dow Jones Newswires
October 19, 2015 06:11 ET (10:11 GMT)
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024
